Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Freedom to Heal Act of 2025
Client: VETERAN MENTAL HEALTH LEADERSHIP COALITION · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Freedom to Heal Act (H.R.6434/S.3346)
Freedom to Heal Act of 2025
Client: VETERAN MENTAL HEALTH LEADERSHIP COALITION · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Freedom to Heal Act (H.R.6434/S.3346) & federal funding for psychedelic medicine research
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NEUROS MEDICAL, INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · third_quarter · Q3
Issues related to medical device reimbursement
Issues related to medical device access
Issues related to medical device access
Source: Senate LDA
| HAPPIEST BABY, INC. |
| 4 |
| 2024–2025 |
| MEDIFY AIR | 4 | 2024–2025 |
| NEUROS MEDICAL, INC. | 4 | 2026 |
| DR. BROWNS COMPANY | 3 | 2026 |
| BALLAD HEALTH | 2 | 2024 |
| EDIBLE BRANDS, LLC | 2 | 2026 |
| VETERAN MENTAL HEALTH LEADERSHIP COALITION | 2 | 2026 |
| MITSUBISHI HEAVY INDUSTRIES AMERICA, INC. | 1 | 2026 |
| WASHINGTON SOCCER PROPERTIES, LLC D/B/A WASHINGTON SPIRIT | 1 | 2025 |
Freedom to Heal Act of 2025
Client: REASON FOR HOPE · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Freedom to Heal Act (H.R.6434/S.3346)
Hemp Planting Predictability Act
Client: EDIBLE BRANDS, LLC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R.7024/S.3686, Hemp Planting Predictability Act
Hemp Enforcement, Modernization, and Protection Act
Client: EDIBLE BRANDS, LLC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Low-dose hemp-derived cannabinoid regulation; H.R.7212, Hemp Enforcement, Modernization, and Protection (HEMP) Act; S.3474,Cannabinoid Safety and Regulation Act (CSRA)
Issues related to country of origin transparency; issues related to unfair competition from overseas manufacturers; S.294 COOL Online Act
Issues related to country of origin transparency; issues related to unfair competition from overseas manufacturers; S.294 COOL Online Act
Freedom to Heal Act (H.R.6434/S.3346)
Freedom to Heal Act of 2025
Client: VETERAN MENTAL HEALTH LEADERSHIP COALITION · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Freedom to Heal Act (H.R.6434/S.3346) & federal funding for psychedelic medicine research
Freedom to Heal Act of 2025
Client: VETERAN MENTAL HEALTH LEADERSHIP COALITION · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Freedom to Heal Act (H.R.6434/S.3346)
Cannabinoid Safety and Regulation Act
Client: EDIBLE BRANDS, LLC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Low-dose hemp-derived cannabinoid regulation; H.R.7212, Hemp Enforcement, Modernization, and Protection (HEMP) Act; S.3474,Cannabinoid Safety and Regulation Act (CSRA)
Hemp Planting Predictability Act
Client: EDIBLE BRANDS, LLC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R.7024/S.3686, Hemp Planting Predictability Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: HEIMDAL, INC. · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
45Q Tax Credit; S.425/H.R.1003 - Enhancing Energy Recovery Act; H.R.1, Enhancing Energy Recovery Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: HEIMDAL, INC. · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
45Q Tax Credit; S.425/H.R.1003 - Enhancing Energy Recovery Act; H.R.1, Enhancing Energy Recovery Act.
Enhancing Energy Recovery Act
Client: HEIMDAL, INC. · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
45Q Tax Credit; S.425/H.R.1003 - Enhancing Energy Recovery Act; H.R.1, Enhancing Energy Recovery Act.
Enhancing Energy Recovery Act
Client: HEIMDAL, INC. · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
45Q Tax Credit; S.425/H.R.1003 - Enhancing Energy Recovery Act
Enhancing Energy Recovery Act
Client: HEIMDAL, INC. · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
45Q Tax Credit; S.425/H.R.1003 - Enhancing Energy Recovery Act; H.R.1, Enhancing Energy Recovery Act.
Women’s Protection in Telehealth Act
Client: GRINDR, LLC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Draft age verification legislation; S.1586/H.R.1349 - App Store Accountability Act
STATES 2.0 Act
Client: COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION (CPEAR) · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Cannabis legalization and regulation; H.R. 2934- STATES 2.0 Act
STATES 2.0 Act
Client: COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION (CPEAR) · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Cannabis legalization and regulation; H.R. 2934- STATES 2.0 Act
Primacy Certainty Act of 2025
Client: HEIMDAL, INC. · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
EPA permitting timelines; H.R.4880/S.2505, Primacy Certainty Act of 2025
Primacy Certainty Act of 2025
Client: HEIMDAL, INC. · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
EPA permitting timelines; H.R.4880/S.2505, Primacy Certainty Act of 2025
Issues related to funding, procurement, and value of air purifiers; H.R.566/S. 147, Cleaner Air Spaces Act; H.R. 903/S. 341, Smoke & Heat Ready Communities Act.
Issues related to funding and procurement of air purifiers; H.R.566/S. 147, Cleaner Air Spaces Act; H.R. 903/S. 341, Smoke & Heat Ready Communities Act.
Issues related to funding and procurement of air purifiers; H.R.566/S. 147, Cleaner Air Spaces Act; H.R. 903/S. 341, Smoke & Heat Ready Communities Act.
Freedom to Heal Act of 2025
Client: REASON FOR HOPE · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Freedom to Heal Act (H.R.6434/S.3346)
Smoke and Heat Ready Communities Act of 2025
Client: MEDIFY AIR · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Issues related to funding and procurement of air purifiers; H.R.566/S. 147, Cleaner Air Spaces Act; H.R. 903/S. 341, Smoke & Heat Ready Communities Act.
Smoke and Heat Ready Communities Act of 2025
Client: MEDIFY AIR · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Issues related to funding and procurement of air purifiers; H.R.566/S. 147, Cleaner Air Spaces Act; H.R. 903/S. 341, Smoke & Heat Ready Communities Act.
Smoke and Heat Ready Communities Act of 2025
Client: MEDIFY AIR · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Issues related to funding, procurement, and value of air purifiers; H.R.566/S. 147, Cleaner Air Spaces Act; H.R. 903/S. 341, Smoke & Heat Ready Communities Act.
Issues related to funding and procurement of air purifiers; H.R.566/S. 147, Cleaner Air Spaces Act; H.R. 903/S. 341, Smoke & Heat Ready Communities Act.
Issues related to funding and procurement of air purifiers; H.R.566/S. 147, Cleaner Air Spaces Act; H.R. 903/S. 341, Smoke & Heat Ready Communities Act.
Issues related to funding, procurement, and value of air purifiers; H.R.566/S. 147, Cleaner Air Spaces Act; H.R. 903/S. 341, Smoke & Heat Ready Communities Act.
Draft age verification legislation; S.1586/H.R.1349 - App Store Accountability Act
EPA permitting timelines; H.R.4880/S.2505, Primacy Certainty Act of 2025
EPA permitting timelines; H.R.4880/S.2505, Primacy Certainty Act of 2025
Freedom to Heal Act (H.R.6434/S.3346)
Smoke and Heat Ready Communities Act of 2025
Client: MEDIFY AIR · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Issues related to funding and procurement of air purifiers; H.R.566/S. 147, Cleaner Air Spaces Act; H.R. 903/S. 341, Smoke & Heat Ready Communities Act.
Smoke and Heat Ready Communities Act of 2025
Client: MEDIFY AIR · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Issues related to funding, procurement, and value of air purifiers; H.R.566/S. 147, Cleaner Air Spaces Act; H.R. 903/S. 341, Smoke & Heat Ready Communities Act.
Smoke and Heat Ready Communities Act of 2025
Client: MEDIFY AIR · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Issues related to funding and procurement of air purifiers; H.R.566/S. 147, Cleaner Air Spaces Act; H.R. 903/S. 341, Smoke & Heat Ready Communities Act.
45Q Tax Credit; S.425/H.R.1003 - Enhancing Energy Recovery Act; H.R.1, Enhancing Energy Recovery Act.
45Q Tax Credit; S.425/H.R.1003 - Enhancing Energy Recovery Act; H.R.1, Enhancing Energy Recovery Act.
45Q Tax Credit; S.425/H.R.1003 - Enhancing Energy Recovery Act
To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
Client: REASON FOR HOPE · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R.1393/S.689 - Breakthrough Therapies Act; issues related to psychedelic-assisted therapy
To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
Client: REASON FOR HOPE · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R.1393/S.689 - Breakthrough Therapies Act; issues related to psychedelic-assisted therapy
To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
Client: REASON FOR HOPE · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R.1393/S.689 - Breakthrough Therapies Act; issues related to psychedelic-assisted therapy
Black Maternal Health Momnibus Act
Client: HAPPIEST BABY, INC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Issues related to coverage and policy for medical devices for infant sleep; issues related to maternal mortality and perinatal care, generally; H.R.937, Tech To Save Moms Act; H.R.909 Moms Matter Act; H.R.3305 - Black Maternal Health Momnibus Act
Save Rural Hospitals Act of 2023
Client: BALLAD HEALTH · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally.
Save Rural Hospitals Act of 2023
Client: BALLAD HEALTH · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally.
Protecting America from Seasonal and Pandemic Influenza Act of 2023
Client: COALITION TO STOP FLU · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R. 5846, Protecting America from Seasonal and Pandemic Influenza Act; S. 3219, Protecting America from Seasonal and Pandemic Influenza Act; reauthorization of the Pandemic All-Hazards Preparedness Act; FY25 Labor-HHS Appropriations, funding related to public health, pandemic preparedness, and flu planning and response.
Protecting America from Seasonal and Pandemic Influenza Act of 2023
Client: COALITION TO STOP FLU · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R. 5846, Protecting America from Seasonal and Pandemic Influenza Act; S. 3219, Protecting America from Seasonal and Pandemic Influenza Act.
STATES 2.0 Act
Client: COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION (CPEAR) · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Cannabis legalization and regulation; H.R.6673 - STATES 2.0 Act
STATES 2.0 Act
Client: COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION (CPEAR) · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Cannabis legalization and regulation; H.R.6673 - STATES 2.0 Act
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R. 5846, Protecting America from Seasonal and Pandemic Influenza Act; S. 3219, Protecting America from Seasonal and Pandemic Influenza Act.
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R. 5846, Protecting America from Seasonal and Pandemic Influenza Act; S. 3219, Protecting America from Seasonal and Pandemic Influenza Act; reauthorization of the Pandemic All-Hazards Preparedness Act; FY25 Labor-HHS Appropriations, funding related to public health, pandemic preparedness, and flu planning and response.
A bill to amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
Client: REASON FOR HOPE · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R.1393/S.689 - Breakthrough Therapies Act; issues related to psychedelic-assisted therapy
A bill to amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
Client: REASON FOR HOPE · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R.1393/S.689 - Breakthrough Therapies Act; issues related to psychedelic-assisted therapy
A bill to amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
Client: REASON FOR HOPE · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R.1393/S.689 - Breakthrough Therapies Act; issues related to psychedelic-assisted therapy
Save Rural Hospitals Act of 2023
Client: BALLAD HEALTH · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally.
Save Rural Hospitals Act of 2023
Client: BALLAD HEALTH · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally.
Issues related to coverage and policy for medical devices for infant sleep; issues related to maternal mortality and perinatal care, generally; H.R.937, Tech To Save Moms Act; H.R.909 Moms Matter Act; H.R.3305 - Black Maternal Health Momnibus Act
Issues related to coverage and policy for medical devices for infant sleep; issues related to maternal mortality and perinatal care, generally; H.R.937, Tech To Save Moms Act; H.R. 909, Moms Matter Act
Issues related to coverage and policy for medical devices for infant sleep; issues related to maternal mortality and perinatal care, generally; H.R.937, Tech To Save Moms Act; H.R.909 Moms Matter Act; H.R.3305 - Black Maternal Health Momnibus Act
Issues related to coverage and policy for medical devices for infant sleep; issues related to maternal mortality and perinatal care, generally; H.R.937, Tech To Save Moms Act; H.R. 909, Moms Matter Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DR. BROWNS COMPANY via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · third_quarter · Q3
Issues related to online marketplace transparency, fair competition, and the impact of direct-to-consumer foreign sellers on U.S. manufacturers.
Issues related to country of origin transparency; issues related to unfair competition from overseas manufacturers; S.294 COOL Online Act
Filing targets: Executive Office of the President (EOP), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
NEUROS MEDICAL, INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · second_quarter · Q2
Issues related to medical device access
Issues related to medical device access
Issues related to medical device reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DR. BROWNS COMPANY via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · second_quarter · Q2
Issues related to online marketplace transparency, fair competition, and the impact of direct-to-consumer foreign sellers on U.S. manufacturers
Issues related to country of origin transparency; issues related to unfair competition from overseas manufacturers; S.294 COOL Online Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DR. BROWNS COMPANY via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · second_quarter · RR
Advocacy related to trade enforcement, consumer product safety, intellectual property protection, online marketplace practices, and regulatory policy affecting U.S. manufacturers of maternal and infant health products.
Advocacy related to trade enforcement, consumer product safety, intellectual property protection, online marketplace practices, and regulatory policy affecting U.S. manufacturers of maternal and infant health products.
Advocacy related to trade enforcement, consumer product safety, intellectual property protection, online marketplace practices, and regulatory policy affecting U.S. manufacturers of maternal and infant health products.
Advocacy related to trade enforcement, consumer product safety, intellectual property protection, online marketplace practices, and regulatory policy affecting U.S. manufacturers of maternal and infant health products.
VETERAN MENTAL HEALTH LEADERSHIP COALITION via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · first_quarter · Q1
Veterans mental health research & treatment
Freedom to Heal Act (H.R.6434/S.3346)
Issues related to funding for psychedelics research and psychedelic-assisted therapy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REASON FOR HOPE via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · first_quarter · Q1
Issues related to funding for psychedelics research and psychedelic-assisted therapy
Veterans mental health research & treatment
Freedom to Heal Act (H.R.6434/S.3346)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDIBLE BRANDS, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · first_quarter · Q1
Low-dose hemp-derived cannabinoid regulation; H.R.7212, Hemp Enforcement, Modernization, and Protection (HEMP) Act; S.3474,Cannabinoid Safety and Regulation Act (CSRA)
H.R.7024/S.3686, Hemp Planting Predictability Act
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NEUROS MEDICAL, INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · first_quarter · Q1
Issues related to medical device reimbursement
Issues related to medical device access
Issues related to medical device access
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MITSUBISHI HEAVY INDUSTRIES AMERICA, INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · first_quarter · Q1
Issues related to energy and climate technology
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
EDIBLE BRANDS, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · first_quarter · RR
Issues related to the 2025 hemp ban and regulation of low-dose, hemp-derived CBD/THC products.
Issues related to the 2025 hemp ban and regulation of low-dose, hemp-derived CBD/THC products.
Issues related to the 2025 hemp ban and regulation of low-dose, hemp-derived CBD/THC products.
NEUROS MEDICAL, INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · first_quarter · RR
Defense - Medical device access; MMM - Issues related to medical device reimbursement; VA - Medical device access
Defense - Medical device access; MMM - Issues related to medical device reimbursement; VA - Medical device access
Defense - Medical device access; MMM - Issues related to medical device reimbursement; VA - Medical device access
VETERAN MENTAL HEALTH LEADERSHIP COALITION via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · first_quarter · RR
Freedom to Heal Act (H.R.6434/S.3346) & federal funding for psychedelic medicine research
GRINDR, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · fourth_quarter · Q4
IVF and surrogacy access for same sex couples; PrEP and HIV test kit access
PEPFAR funding; international human rights as it relates to the LGBTQ+ community
Age verification legislation
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, Treasury, Dept of
OTSUKA AMERICA PHARMACEUTICAL, INC via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · fourth_quarter · Q4
Research, development, and reimbursement of novel serotonergic agonists for mental health conditions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEIMDAL, INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · fourth_quarter · Q4
EPA permitting timelines; H.R.4880/S.2505, Primacy Certainty Act of 2025
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REASON FOR HOPE via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · fourth_quarter · Q4
Issues related to psychedelics research and psychedelic-assisted therapy
Veterans mental health research & treatment
Freedom to Heal Act (H.R.6434/S.3346)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION TO STOP FLU via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · fourth_quarter · Q4
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
MEDIFY AIR via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · third_quarter · 3T
Issues related to funding, procurement, and value of air purifiers; H.R.566/S. 147, Cleaner Air Spaces Act; H.R. 903/S. 341, Smoke & Heat Ready Communities Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
OTSUKA AMERICA PHARMACEUTICAL, INC via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · third_quarter · Q3
Research, development, and reimbursement of psychedelics for mental health conditions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REASON FOR HOPE via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · third_quarter · Q3
Issues related to psychedelics research and psychedelic-assisted therapy
Veterans mental health research & treatment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION (CPEAR) via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · third_quarter · Q3
Cannabis legalization and regulation; H.R. 2934- STATES 2.0 Act
Filing targets: HOUSE OF REPRESENTATIVES
HEIMDAL, INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · third_quarter · Q3
EPA permitting timelines; H.R.4880/S.2505, Primacy Certainty Act of 2025
45Q Tax Credit; S.425/H.R.1003 - Enhancing Energy Recovery Act; H.R.1, Enhancing Energy Recovery Act.
Carbon capture facility deployment, development, and incentives
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GRINDR, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · third_quarter · Q3
IVF and surrogacy access for same sex couples; PrEP and HIV test kit access
PEPFAR funding; international human rights as it relates to the LGBTQ+ community
Draft age verification legislation; S.1586/H.R.1349 - App Store Accountability Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION TO STOP FLU via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · third_quarter · Q3
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
COALITION TO STOP FLU via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · second_quarter · Q2
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
GRINDR, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · second_quarter · Q2
IVF and surrogacy access for same sex couples; PrEP and HIV test kit access
PEPFAR funding; international human rights as it relates to the LGBTQ+ community
Age verification legislation
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, Treasury, Dept of
HEIMDAL, INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · second_quarter · Q2
Carbon capture facility deployment, development, and incentives
EPA permitting timelines; Primacy Certainty Act
45Q Tax Credit; S.425/H.R.1003 - Enhancing Energy Recovery Act; H.R.1, Enhancing Energy Recovery Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REASON FOR HOPE via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · second_quarter · Q2
Issues related to psychedelics research and psychedelic-assisted therapy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION (CPEAR) via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · second_quarter · Q2
Cannabis legalization and regulation; H.R. 2934- STATES 2.0 Act
Filing targets: HOUSE OF REPRESENTATIVES
MEDIFY AIR via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · second_quarter · Q2
Issues related to funding and procurement of air purifiers; H.R.566/S. 147, Cleaner Air Spaces Act; H.R. 903/S. 341, Smoke & Heat Ready Communities Act.
Customs duties related to air purifiers.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
HAPPIEST BABY, INC via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · first_quarter · 1T
Issues related to maternal mortality and perinatal care and Sudden Unexpected Infant Death (SUID), generally
Issues related to Section 301 tariffs
Issues related to military maternal health, issues related to military readiness
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
WASHINGTON SOCCER PROPERTIES, LLC D/B/A WASHINGTON SPIRIT via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · first_quarter · Q1
Issues related to equality in women's sports and the growth of womens soccer.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION TO STOP FLU via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · first_quarter · Q1
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
MEDIFY AIR via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · first_quarter · Q1
Issues related to funding and procurement of air purifiers; H.R.566/S. 147, Cleaner Air Spaces Act; H.R. 903/S. 341, Smoke & Heat Ready Communities Act.
Customs duties related to air purifiers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
HEIMDAL, INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · first_quarter · Q1
Carbon capture facility deployment, development, and incentives
EPA permitting timelines; Primacy Certainty Act
45Q Tax Credit; S.425/H.R.1003 - Enhancing Energy Recovery Act
Filing targets: Energy, Dept of, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
GRINDR, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · first_quarter · Q1
IVF and surrogacy access for same sex couples; PrEP and HIV test kit access
PEPFAR funding; international human rights as it relates to the LGBTQ+ community
Age verification legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · first_quarter · Q1
Research, development, and reimbursement of psychedelics for mental health conditions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REASON FOR HOPE via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · first_quarter · Q1
Issues related to psychedelics research and psychedelic-assisted therapy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · fourth_quarter · Q4
Research, development, and reimbursement of psychedelics for mental health conditions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEIMDAL, INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · fourth_quarter · Q4
Carbon capture incentives
EPA permitting timelines
Carbon capture facility deployment, development, and incentives
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REASON FOR HOPE via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · fourth_quarter · Q4
H.R.1393/S.689 - Breakthrough Therapies Act; issues related to psychedelic-assisted therapy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HAPPIEST BABY, INC via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · fourth_quarter · Q4
Issues related to maternal mortality and perinatal care, generally
Issues related to military maternal health, issues related to military readiness
Issues related to Section 301 tariffs
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MEDIFY AIR via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · fourth_quarter · Q4
Issues related to funding and procurement of air purifiers.
Customs duties related to air purifiers.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES
HAPPIEST BABY, INC via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · third_quarter · Q3
Issues related to Section 301 tariffs
Issues related to coverage and policy for medical devices for infant sleep; issues related to maternal mortality and perinatal care, generally; H.R.937, Tech To Save Moms Act; H.R.909 Moms Matter Act; H.R.3305 - Black Maternal Health Momnibus Act
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Small Business Administration (SBA)
COALITION TO STOP FLU via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · third_quarter · Q3
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R. 5846, Protecting America from Seasonal and Pandemic Influenza Act; S. 3219, Protecting America from Seasonal and Pandemic Influenza Act.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
BALLAD HEALTH via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · third_quarter · Q3
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEIMDAL, INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · third_quarter · Q3
Carbon capture facility deployment, development, and incentives
Carbon capture incentives
EPA permitting timelines
Filing targets: Energy, Dept of, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
REASON FOR HOPE via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · third_quarter · Q3
H.R.1393/S.689 - Breakthrough Therapies Act; issues related to psychedelic-assisted therapy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION (CPEAR) via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · third_quarter · Q3
Cannabis legalization and regulation; H.R.6673 - STATES 2.0 Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · third_quarter · RR
Research, development, and reimbursement of novel mental health treatments
BALLAD HEALTH via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · second_quarter · Q2
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION TO STOP FLU via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · second_quarter · Q2
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R. 5846, Protecting America from Seasonal and Pandemic Influenza Act; S. 3219, Protecting America from Seasonal and Pandemic Influenza Act; reauthorization of the Pandemic All-Hazards Preparedness Act; FY25 Labor-HHS Appropriations, funding related to public health, pandemic preparedness, and flu planning and response.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
HAPPIEST BABY, INC via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · second_quarter · Q2
Issues related to coverage and policy for medical devices for infant sleep; issues related to maternal mortality and perinatal care, generally; H.R.937, Tech To Save Moms Act; H.R. 909, Moms Matter Act
Issues related to Section 301 tariffs
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
HEIMDAL, INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · second_quarter · Q2
Carbon capture facility deployment, development, and incentives
Carbon capture incentives
EPA permitting timelines
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION (CPEAR) via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · second_quarter · Q2
Cannabis legalization and regulation; H.R.6673 - STATES 2.0 Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REASON FOR HOPE via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · second_quarter · Q2
H.R.1393/S.689 - Breakthrough Therapies Act; issues related to psychedelic-assisted therapy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEIMDAL, INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · second_quarter · RR
Carbon capture facility deployment, development, and incentives
Carbon capture facility deployment, development, and incentives
Carbon capture facility deployment, development, and incentives